E-cadherin is a transmembrane glycoprotein which mediates a calcium depende
nt homophilic interaction among epithelial cells. The altered expression an
d gene mutations of E-cadherin adhesion molecule have been frequently obser
ved in various tumors. Several invasive carcinomas showed cell-cell adhesio
n loss although the tumor cells expressed considerable amounts of E-cadheri
n protein. The purpose of this study was to evaluate the role of E-cadherin
gene alterations in genesis and progression of bladder carcinoma by mutati
on analysis of coding region, expression analysis and microsatellite instab
ility at E-cadherin chromosome locus. We analyzed 30 bladder carcinoma (28
transitional and 2 squamous cell carcinoma) at different stage and grade. T
he mutation analysis showed that in one case there was a presence of a poin
t mutation at codon 846 that consisted of a G (AGC) to C (ACC) transversion
resulting in the replacement of R to T. In another sample the sequence ana
lysis revealed a same-sense mutation at the codon 785 (AAC - AAT). The stud
y of E-cadherin mRNA by Northern blot analysis showed that there were no di
fferences of mRNA levels between tumor and normal mucosa samples. We noted
that invasive and anaplastic tumors showed a trend to loss of expression, e
ven if we did not find any statistically significant differences. The micro
satellite analysis showed the presence of genomic instability in proximity
of the E-cadherin gene. Nine out of 30 (30%) specimens presented molecular
alterations in at least one out of 2 loci (D16S260 and D16S301) analyzed. T
he comparison between microsatellite mutations and clinical-histopathologic
al parameters revealed a higher number of alterations in invasive respect t
o superficial tumors (p=0.014). On the other hand, there were no statistica
l differences regarding the correlation with pathological grade. These obse
rvations, which, nevertheless, need to be confirmed in a larger number of p
atients, suggest that alterations of E-cadherin gene may be related to path
obiology of bladder cancer development and clinical progression.